Clinical trials
Phase 3 Head and Neck Neoplasms trials in Portugal
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
11 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2011 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 2 |
| 2022 | 1 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 4 |
| Active, not recruiting | 3 |
| Completed | 3 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| GlaxoSmithKline | 2 |
| AstraZeneca | 1 |
| Boehringer Ingelheim | 1 |
| EMD Serono Research & Development Institute, Inc. | 1 |
| Hoffmann-La Roche | 1 |
| Incyte Corporation | 1 |
| Merck KGaA, Darmstadt, Germany | 1 |
| Merck Sharp & Dohme LLC | 1 |
| Merus B.V. | 1 |
| Sanofi | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Head and Neck Neoplasms | 11 |
| Squamous Cell Carcinoma of Head and Neck | 4 |
| Laryngeal Diseases | 3 |
| Neoplasms | 3 |
| Adenocarcinoma | 1 |
| Bronchial Diseases | 1 |
| Carcinoma | 1 |
| Carcinoma, Bronchogenic | 1 |
| Carcinoma, Non-Small-Cell Lung | 1 |
| Lung Diseases | 1 |
Trials
Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.